Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple urine test may spot kidney risk in spina bifida

NCT ID NCT06041334

Recruiting now Knowledge-focused Sponsor: Rennes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether certain substances in urine (called biomarkers) can predict kidney damage in people with spina bifida. Researchers will measure these biomarkers in 50 patients and compare them to a standard risk score. The goal is to find a non-invasive way to monitor kidney health, but this is an observational study, not a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple urine test to predict kidney damage risk in spina bifida patients, helping doctors intervene earlier.
What could go wrong
This is a small, early-stage observational study, not a treatment trial. The biomarkers may not reliably predict kidney damage, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINA BIFIDA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spina bifida

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINA BIFIDA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rennes University Hospital

    RECRUITING

    Rennes, CHU de Rennes, 35033, France

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.